Does immunosuppressive treatment entail an additional risk for children with rheumatic diseases? A survey-based study in the era of COVID-19

SARS-CoV-2 infection in children: Transmission dynamics and clinical characteristics

(2020) Qing Cao et al.   JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION

Clinical and CT features in pediatric patients with COVID‐19 infection: Different points from adults

(2020) Wei Xia et al.   PEDIATRIC PULMONOLOGY

COVID-19 pneumonia in a large cohort of patients treated with biological and targeted synthetic antirheumatic drugs

(2020) Edoardo Conticini et al.   ANNALS OF THE RHEUMATIC DISEASES

What is the true incidence of COVID-19 in patients with rheumatic diseases?

(2020) Ennio Giulio Favalli et al.   ANNALS OF THE RHEUMATIC DISEASES

Clinical course of COVID-19 in a series of patients with chronic arthritis treated with immunosuppressive targeted therapies

(2020) Sara Monti et al.   ANNALS OF THE RHEUMATIC DISEASES

How to handle patients with autoimmune rheumatic and inflammatory bowel diseases in the COVID-19 era: An expert opinion

(2020) Piercarlo Sarzi-Puttini et al.   AUTOIMMUNITY REVIEWS

COVID-19 infection and rheumatoid arthritis: Faraway, so close!

(2020) Ennio Giulio Favalli et al.   AUTOIMMUNITY REVIEWS

Trained Immunity: a Tool for Reducing Susceptibility to and the Severity of SARS-CoV-2 Infection

(2020) Mihai G. Netea et al.   CELL

COVID-19 – Considerations for the paediatric rheumatologist

(2020) Christian M. Hedrich   CLINICAL IMMUNOLOGY

In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)

(2020) Xueting Yao et al.   CLINICAL INFECTIOUS DISEASES

Rheumatologists’ perspective on coronavirus disease 19 (COVID-19) and potential therapeutic targets

(2020) Durga Prasanna Misra et al.   CLINICAL RHEUMATOLOGY

Structural and molecular modelling studies reveal a new mechanism of action of chloroquine and hydroxychloroquine against SARS-CoV-2 infection

(2020) Jacques Fantini et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Recommendations for coronavirus infection in rheumatic diseases treated with biologic therapy

(2020) Angela Ceribelli et al.   JOURNAL OF AUTOIMMUNITY

The Question of Whether to Remain on Therapy for Chronic Rheumatic Diseases in the Setting of the Covid-19 Pandemic

(2020) Randy Q. Cron et al.   JOURNAL OF RHEUMATOLOGY

Absence of severe complications from SARS-CoV-2 infection in children with rheumatic diseases treated with biologic drugs

(2020) Giovanni Filocamo et al.   JOURNAL OF RHEUMATOLOGY

The Rheumatologist’s Role in COVID-19

(2020) RANDY Q. CRON et al.   JOURNAL OF RHEUMATOLOGY

Hydroxychloroquine: A Potential Ethical Dilemma for Rheumatologists during the COVID-19 Pandemic

(2020) ROSIE SCUCCIMARRI et al.   JOURNAL OF RHEUMATOLOGY

COVID-19: consider cytokine storm syndromes and immunosuppression

(2020) Puja Mehta et al.   LANCET

Coronavirus Infections in Children Including COVID-19

(2020) Petra Zimmermann et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Insight into COVID‐2019 for pediatricians

(2020) Yuanzhe Li et al.   PEDIATRIC PULMONOLOGY

Novel coronavirus infection in children outside of Wuhan, China

(2020) Qinxue Shen et al.   PEDIATRIC PULMONOLOGY

COVID-19 and what pediatric rheumatologists should know: a review from a highly affected country

(2020) Francesco Licciardi et al.   Pediatric Rheumatology

Epidemiology of COVID-19 Among Children in China

(2020) Yuanyuan Dong et al.   PEDIATRICS

COVID-19: an unexpected indication for anti-rheumatic therapies?

(2020) Bruno Lucchino et al.   RHEUMATOLOGY

Coronavirus disease 2019 (COVID-19) and anti-rheumatic drugs

(2020) Tsvetoslav Georgiev   RHEUMATOLOGY INTERNATIONAL

Dealing with COVID-19 in a Pediatric Rheumatology Unit in Italy

(2020) Stefania Costi et al.   PEDIATRIC DRUGS

Childhood Rheumatic Diseases and COVID-19 Pandemic: An Intriguing Linkage and a New Horizon

(2020) Fatih Haşlak et al.   Balkan Medical Journal

American College of Rheumatology Guidance for the Management of Adult Patients with Rheumatic Disease During the COVID‐19 Pandemic

(2020) Ted R. Mikuls et al.   Arthritis & Rheumatology

Clinical Characteristics of Children with Coronavirus Disease 2019 in Hubei, China

(2020) Fang Zheng et al.   Current Medical Science

The anti-viral facet of anti-rheumatic drugs: Lessons from COVID-19

(2020) Carlo Perricone et al.   JOURNAL OF AUTOIMMUNITY

Clinical and epidemiological features of 36 children with coronavirus disease 2019 (COVID-19) in Zhejiang, China: an observational cohort study

(2020) Haiyan Qiu et al.   LANCET INFECTIOUS DISEASES

Management of pediatric rheumatic patients in Kazakhstan during the coronavirus disease 2019 (COVID-19) pandemic

(2020) Zaure Mukusheva et al.   RHEUMATOLOGY INTERNATIONAL

Management of childhood-onset autoinflammatory diseases during the COVID-19 pandemic

(2020) Fatih Haslak et al.   RHEUMATOLOGY INTERNATIONAL

Implications of COVID-19 in pediatric rheumatology

(2020) Ezgi Deniz Batu et al.   RHEUMATOLOGY INTERNATIONAL

Paradoxical Effect of Chloroquine Treatment in Enhancing Chikungunya Virus Infection

(2018) Pierre Roques et al.   Viruses-Basel

The frequency of infections in patients with juvenile idiopathic arthritis on biologic agents: 1-year prospective study

(2018) Deniz Aygun et al.   CLINICAL RHEUMATOLOGY

Coronaviruses — drug discovery and therapeutic options

(2016) Alimuddin Zumla et al.   NATURE REVIEWS DRUG DISCOVERY